gms | German Medical Science

73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

29.05. - 01.06.2022, Köln

A 6-year retrograde series study of the effect of Acenocoumarol on the outcome after immediate single burr hole drainage of CSDH – a single centre example

Der Effekt von Acenocoumarol auf das Outcome nach sofortiger einseitiger Bohrlochtrepanation des chronischen Subduralhämatoms: eine monozentrische, 6-jährige retrograde Fallserie

Meeting Abstract

Search Medline for

  • presenting/speaker Evropi Amanatidou - General Hospiatl of Thessaloniki G.Papanikolaou, Department of Neurosurgery, Thessaloniki, Griechenland
  • Pavlos Christoglou - General Hospiatl of Thessaloniki G.Papanikolaou, Department of Neurosurgery, Thessaloniki, Griechenland

Deutsche Gesellschaft für Neurochirurgie. 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie. Köln, 29.05.-01.06.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. DocJ-HSNC10

doi: 10.3205/22dgnc514, urn:nbn:de:0183-22dgnc5145

Published: May 25, 2022

© 2022 Amanatidou et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions. Acenocoumarol use in these patients can pose a challenge for the neurosurgeon. The risks associated with Acenocoumarol cannot always be directly compared to the risk of rebleeding and recurrence. In this poster we present the data our Neurosurgical department has collected in the past 6 years on the treatment of such patients.

Methods: We classified the patients into two groups, the first being that of patients under Acenocoumarol treatment and the second being that of patients under no anticoagulation or antiplatelet therapy. Patients of both groups underwent a single burrhole drainage, which is the surgery of choice for CSDH in our department, during the first 24h after admission. We then devided the outcome observed in hospitalised and discharged patients during a 6month follow-up, into two grand categories, a positive outcome which mostly included patients with improved neurological status and a negative outcome which included patients with immediate deterioration and in need of emergency re-surgery, or during follow-up, as well as the cases with no improvement of neurological symptoms. We statistically analysed our data using the chi-squared test with the Yates correction.

Results: We included o total of 108 patients out of which 8 patients were under Acenocoumarol treatment and underwent surgery immediately and 100 patients were under no anticoagulant/antiplatelet therapy and underwent immediate surgery. We did not find a statistically significant difference concerning the outcome between patients under Acenocoumarol and those under no such treatment undergoing immediate drainage of a CSDH.

Conclusion: Our study did not detect any influence of Acenocoumarol use on the outcome following a single burrhole drainage of CCSDH.